Prostate-apoptosis response-4 phosphorylation in vascular smooth muscle

Area of Science:

• Cellular Biology
• Physiology
• Molecular Biology

Background:

• Prostate-apoptosis response (Par)-4 is linked to smooth muscle contraction regulation.
• A proposed mechanism involves Par-4 binding to MYPT1, inhibiting myosin light chain phosphatase (MLCP).
• Par-4 phosphorylation at Thr155 was hypothesized to disrupt this interaction, leading to MLCP inhibition and contraction.

Purpose of the Study:

• To test the proposed
• padlock
• hypothesis in a rat caudal artery model.
• To investigate the role of Par-4 phosphorylation in regulating vascular smooth muscle contraction.

Main Methods:

• Used Triton-skinned rat caudal artery tissue.
• Performed co-immunoprecipitation to assess Par-4 and MYPT1 interaction.
• Analyzed protein phosphorylation using Western blotting after microcystin treatment.
• Utilized kinase inhibitors (staurosporine, ZIPK, ROCK, PKC inhibitors) and constitutively-active ZIPK.

Main Results:

• Par-4 was associated with the contractile machinery and co-immunoprecipitated with MYPT1.
• Microcystin induced Par-4 phosphorylation at Thr155 but not dissociation from MYPT1.
• MYPT1 phosphorylation preceded Par-4 phosphorylation.
• Par-4 phosphorylation was inhibited by staurosporine but not by ZIPK, Rho-kinase, or PKC inhibitors, nor by active ZIPK.

Conclusions:

• Phosphorylation of Par-4 does not regulate vascular smooth muscle contraction via dissociation from MYPT1.
• The proposed mechanism of Par-4 regulating MLCP inhibition by controlling MYPT1 phosphorylation is not supported in this system.
• The role of Par-4 phosphorylation in smooth muscle contraction requires further investigation.